• 1
    Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245251.
  • 2
    Lechler RI, Ng WF, Steinman RM. Dendritic cells in transplantation – friend or foe. Immunity 2001; 14: 357368.DOI: 10.1016/s1074-7613(01)00116-9
  • 3
    Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for tolerance induction: guided not misguided missiles. Trends Immunol 2001; 22: 437442.
  • 4
    Peugh W, Austyn J, Carter N, Wood K, Morris P. Inability of dendritic cells to prevent the blood transfusion effect in a mouse cardiac allograft. Transplantation 1987; 44: 706711.
  • 5
    Demetris A, Murase N, Starzl T. Donor dendritic cells after liver and heart allotransplantation under short-term immunosuppression. Lancet 1992; 339: 1610.
  • 6
    Qian S, Demetris A, Murase N, Rao A, Fung J, Starzl T. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916923.
  • 7
    Lu L, Rudert W, Qian S et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allgraft reccipients in response to granulocyte/macrophage colony stimulating factor. J Exp Med 1995; 182: 379387.
  • 8
    Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. Granulocyte/macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 13661370.
  • 9
    Fu F, Li Y, Qian S et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+,CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 1996; 62: 659665.
  • 10
    Josien R, Heslan M, Brouard S, Soulillou J-P, Cuturi M-C. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion.. Blood 1998; 92: 45394544.
  • 11
    Garrovillo M, Ali A, Oluwole S. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 1999; 68: 18271834.
  • 12
    Min W-P, Gorczynski R, Huang X-Y et al. Dendritic cells genetically engineered to express Fas Ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J Immunology 2000; 164: 161167.
  • 13
    Lu L, Li W, Fu F et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 18081815.
  • 14
    Niimi M, Shirasugi N, Ikeda Y, Kan S, Takami H, Hamano K. Operational tolerance induced by pretreatment with donor dendritic cells under blockade of CD40 pathway. Transplantation 2001; 72: 15561562.
  • 15
    Thomas J, Contreras J, Jiang X et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999; 68: 16601673.
  • 16
    Jonuleit L, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000; 192: 12131222.
  • 17
    Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 2001; 193: 233238.
  • 18
    Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Ann Rev Immunol 2000; 18: 767811.
  • 19
    Ardavin C, Martinez del Hoyo G, Martin P et al. Origin and differentiation of dendritic cells. Trends Immunology 2001; 22: 691700.
  • 20
    Bjork P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte macrophage -colony stimulating factor-treated mice. Blood 2001; 98: 35203526.
  • 21
    Hochrein H, Shortman K, Vremec D, Scott B, Hertzog P, O'Keefe M. Differential production of IL-12, IFN-α, and IFN-γ by mouse dendritic cell subsets. J Immunol 2001; 166: 54485455.
  • 22
    Den Haan JMM, Lehar SM, Bevan MJ. CD8+ but not CD8 dendritic cells cross prime cytotoxic T cells in vivo. J Exp Med 1999; 192: 16851695.
  • 23
    Pulendran B, Maraskovsky E, Banchereau J, Maliszewski C. Modulating the immune response with dendritic cells and their growth factors. Trends Immunol 2001; 22: 4147.
  • 24
    Lotze MT, Thomson AW. Dendritic Cells: Biology and Clinical Applications, 2nd edn. San Diego: Academic Press; 2001.
  • 25
    Mellman I, Steinman RM. Dendritic cells: specialized and regulated antigen processing machines. Cell 2001; 106: 255258.
  • 26
    Sauter B, Albert ML, Francisco L, Larrson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000; 191: 423433.
  • 27
    Huang F-P, Platt N, Wykes M et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J Exp Med 2000; 191: 435443.
  • 28
    Hawiger D, Inaba K, Dorsett Y et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 2001; 194: 769779.
  • 29
    Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191: 411416.
  • 30
    Albert M, Jegathesan M, Darnell K. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001; 2: 10101017.DOI: 10.1038/ni722
  • 31
    Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352358.
  • 32
    Auchincloss H Jr, Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of ‘indirect’ recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci USA 1993; 90: 33733377.
  • 33
    Garrovillo M, Ali A, Depaz HA et al. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant 2001; 1: 129138.DOI: 10.1034/j.1600-6143.2001.001002129.x
  • 34
    Qian S, Lu L, Fu F et al. Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer cell, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation 1998; 65: 15901598.
  • 35
    Qian S, Lu L, Fu F et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158: 46544661.
  • 36
    Lu L, Qian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 56765684.
  • 37
    Lu L, Li W, Zhong C et al. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb. Transplantation 1999; 68: 747757.
  • 38
    Li Y, Li XC, Zheng X, Wells AD, Turka LA, Strom TB. Blocking of both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral tolerance. Nat Med 1999; 5: 12981302.DOI: 10.1038/15256
  • 39
    Yan Y, Shastry S, Richard C et al. Posttransplant administration of donor leukocytes induces long-term acceptance of kidney or liver transplants by an activation-associated immune mechanism. J Immunol 2001; 166: 52585264.
  • 40
    Groux H, O'Garra A, Bigler M et al. T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997; 389: 737741.
  • 41
    Roncarlo M-G, Levings MK, Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J Exp Med 2001; 193: 59.
  • 42
    Lu L, Bonham CA, Liang X et al. Liver-derived DEC205+B220+CD19 dendritic cells regulate T cell reponses. J Immunol 2001; 166: 70427052.
  • 43
    Kuwana M, Kaburaki J, Wright TM, Kawakami Y, Ikeda Y. Induction of antigen-specific human CD4+T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 2001; 31: 25472557.
  • 44
    Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999; 48: 23002308.
  • 45
    Arpinati M, Green CL, Heimfeld S, Heuser JE, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 24842490.
  • 46
    Ali A, Garrovillo M, Jin MX, Hardy MA, Oluwole SF. Major histocompatibility complex class I peptide-pulsed host dendritic cells induce antigen-specific acquired thymic tolerance to islet cells. Transplantation 2000; 69: 221226.
  • 47
    Lutz MB, Suri RM, Niimi M et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000; 30: 18131822.
  • 48
    Hackstein H, Morelli AE, Larregina AT et al. Aspirin inhibits the in vivo maturation and in vivo immunostimulatory function of murine myeloid dendritic cells. J Immunol 2001; 165: 70537062.
  • 49
    Giannoukakis N, Bonham CA, Qian S et al. Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligonucleotides. Molecular Therapy 2000; 1: 430437.DOI: 10.1006/mthe.2000.0060
  • 50
    Coates PTH, Krishnan R, Kireta S, Johnston J, Russ GR. Human myeloid dendritic cells transduced with an adenoviral interleukin 10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice. Gene Therapy 2001; 8: 12241233.
  • 51
    Takayama T, Nishioka Y, Lu L, Lotze M, Tahara H, Thomson AW. Retroviral delivery of viral interleukin 10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation 1998; 66: 15671574.
  • 52
    Lee W, Zhong C, Qian S et al. Phenotype, function, in vivo migration and survival of allogeneic dendritic cell precursors genetically engineered to express TGFβ. Transplantation 1998; 66: 18101817.
  • 53
    Lu L, Gambotto A, Lee W-C et al. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Therapy 1999; 6: 554563.
  • 54
    Gorcznski RM, Bransom J, Cattral M et al. Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFβ and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2. Clin Immunol 2000; 95: 182189.DOI: 10.1006/clim.2000.4860
  • 55
    Matsue H, Matsue K, Kusuhara T et al. Immunosuppressive properties of CD95L-transduced ‘killer’ hybrids created by fusing donor-and recipient-derived dendritic cells. Blood 2001; 98: 34653472.
  • 56
    O'Connell PJ, Li W, Wang Z, Specht S, Logar AJ, Thomson AW. Immature and mature CD8 alpha (+) dendritic cells prolong the survival of vascularized heart allografts. J Immunol 2002; 168: 143154.
  • 57
    Hackstein H, Wang Z, Morelli AE et al. Normal donor bone marrow is superior to Flt3L mobilized bone marrow in prolonging heart allograft survival when combined with anti CD40L (CD154) mAb. Am J Transplant 2002 (in press).
  • 58
    Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001; 14: 417424.
  • 59
    Starzl TE, Demetris AJ, Trucco M et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 11271152.
  • 60
    Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism and allograft survival. Immunol Today 1996; 17: 577584; discussion 588.
  • 61
    Grohmann U, Fallarino F, Silla S et al. CD40 Ligation ablates the tolerogenic potential of lymphoid dendritic cells. J Immunol 2001; 166: 277283.
  • 62
    Barber W, Markin J, Laskow D et al. Long term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 7075.
  • 63
    Shapiro R, Rao AS, Fontes P et al. Combined simultaneous kidney/bone marrow transplantation. Transplantation 1995; 60: 14211425.
  • 64
    Pham SM, Rao AS, Zeevi A et al. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg 2000; 69: 345350.
  • 65
    Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001; 1: 233239.DOI: 10.1038/35105088
  • 66
    Morita Y, Yang J, Gupta R et al. Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. J Clin Invest 2001; 107: 12751284.
  • 67
    Kim S, Kim S, Evans C, Ghivizzani S, Oligino T, Robbins P. Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4. J Immunol 2001; 166: 34993505.
  • 68
    Mirenda V, Berton I, Dorling A, Lechler RI. Induction of unresponsiveness in mouse T cells with direct anti-pig specificity in vivo. Immunology 2001; 104 (Suppl. 1): 55 (Abstract).